Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 • 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

July 28, 2023 • 00:26:16
Episode Cover

Should We Transfuse Platelets Prior to CVC Placement?

Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill...

Listen

Episode

February 06, 2018 • 00:22:23
Episode Cover

Reversal Strategies for Life-threatening Bleeding due to DOACs!

He's back!  Bryan Hayes joins the podcast to discuss the latest evidence pertaining to the reversal of life-threatening hemorrhage secondary to the direct oral...

Listen

Episode 0

May 26, 2020 • 00:27:09
Episode Cover

HFNC in COVID-19 Patients - Helpful or Harmful?

As we gain more experience managing critically ill patients with COVID-19 infection there has been a shift away from immediate intubation and towards more...

Listen